Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

Sep 22, 2023 06:39 ET
New Report Reveals Surge in Demand for Operating Room Integration Systems (IOR) Driven by Aging Population and Technological Advancements -
The "Operating Room Integration Systems Market Size by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033" report has been added to's offering....
Sep 22, 2023 06:30 ET
Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its financial results for the third quarter ending October 1, 2023, before market open on October 26, 2023....
Sep 22, 2023 06:24 ET
3D Printing in Aerospace and Defense Market - Global Size & Share Analysis, Growth Trends & Forecasts to 2028 -
The "3D Printing in Aerospace and Defense Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to's offering....
Sep 22, 2023 06:17 ET
Sep 22, 2023 06:00 ET
Merck Announces Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Previously Untreated Locally Advanced
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-A39 trial (also known as EV-302), which was conducted in collaboration with Seagen and Astellas, evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Padcev (enfortumab vedotin-ejfv) versus chemotherapy (gemcitabine plus cisplatin or carboplatin) in patients with previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC). The trial enrolled patients who may or may not be eligible for treatment with cisplatin-based chemo...
Sep 22, 2023 06:00 ET
Vizient Announces Top Performers in Clinical Quality, Supplier Diversity and Environmentally Preferred Sourcing Excellence
Vizient, Inc. today announced 2023’s top performers in clinical quality and supply chain excellence. The awards recognize the work of Vizient provider customers in clinical quality and accountability, supplier diversity and environmentally preferred sourcing excellence. The awards were presented during the 2023 Vizient Connections Summit held Sept. ...
Sep 22, 2023 05:34 ET
OS Achieves 800-Puff Milestone with FEELM Max Technology
A significant mark in the vaping industry was set when OS Vape, a pioneering disposable product series from OS, showcased its dynamic range at the InterTabac from September 14th to 16th in Germany....
Sep 22, 2023 05:00 ET
Calix To Continue 24-Year Leadership in US Rural Broadband, Affirming Commitment to BEAD ‘Build America, Buy America’
Calix, Inc. (NYSE: CALX) will today affirm its commitment to “Build America, Buy America” (BABA) for the Broadband Equity, Access, and Deployment (BEAD) program at an event held at a manufacturing facility operated by its strategic manufacturing solutions provider,
Sep 22, 2023 05:00 ET
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pi
Seagen Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE:4503) today announced positive topline results from the Phase 3 EV-302 clinical trial (also known as KEYNOTE-A39) for PADCEV® (enfortumab vedotin-ejfv) in combination with KEYTRUDA® (pembrolizumab) versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (la/mUC), a form of bladder cancer that has spread to surrounding organs or muscles, or other parts of the body. The EV-302 trial enrolled patients with previously untreated la/mUC who were eligible for cisplatin- or...
Sep 22, 2023 04:10 ET
Mitsubishi Electric Announces Dividend Policy for the First Half of Fiscal 2024
Mitsubishi Electric Corporation (TOKYO:6503) announced today its dividend forecast for the first half (ending September 30, 2023) of the current fiscal year ending March 31, 2024 (fiscal 2024)....
Sep 22, 2023 04:08 ET
CLF Innovative Mold Height Setting and Clamping System: A Breakthrough in Two Platen Injection Molding Machine
Chuan Lih Fa Machinery Works Co. Ltd, popularly known across the globe as CLF, continues its impressive performance as a leading innovator in the field of high-precision and high-performance large plastic injection molding machines. The company’s advanced Two Platen Plastic Injection Molding Machine has now emerged as the most preferred choice for many different industrial applications, especially in the USA. Out of its many features, the most advanced one is its ability to achieve a considerably faster clamping force build-up by shorter locking time and pressure-generation time....
Sep 22, 2023 04:00 ET
Earnix Announces New London Office, Unveils New Tech and Launches Global Modelling Contest at Earnix Eˣcelerate Summit 2023
Earnix, the global provider of intelligent, SaaS solutions for insurers and banks, celebrated its 12th annual Eˣcelerate Summit by announcing a new London office to collaborate with its growing customer base, unveiling Model Accelerator, and launching its first global modelling contest....
Sep 22, 2023 04:00 ET
Europe’s Enterprises Look to Providers to Bridge the CX Gap
Enterprises throughout Europe are rapidly moving from in-house operations to external service providers to meet the growing demand for an enhanced contact center customer experience (CX), according to a new research report published today by Information Services Group (ISG) (Nasdaq:
Sep 22, 2023 03:00 ET
JTI: Combatting Illegal Trade and a Collective Approach to Sustainability Were the Focus at the Global Tobacco and Nicotine Forum in Seoul
The Global Tobacco and Nicotine Forum (GTNF) took place in Seoul, South Korea 19-21 September. “Change the Conversation. Change the Outcome.” was the theme of the conference which brought together hundreds of stakeholders from across the industry, including businesses, research consulting groups, scientists, public policy and regulatory experts and educators, among others, to discuss industry trends and challenges and share best practice thinking....
Sep 22, 2023 02:00 ET
Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Br
Positive topline results from the TROPION-Breast01 phase 3 trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant and clinically meaningful improvement for the primary endpoint of progression-free survival (PFS) compared to investigator’s choice of chemotherapy in patients with inope...
Sep 22, 2023 01:00 ET
Sep 22, 2023 01:00 ET
Innate Pharma Announces Encore Presentation of Interim Results of Phase 2 TELLOMAK Study With Lacutamab With Updated Olsen 2022 Criteria at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 202
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced an encore presentation of interim efficacy results from the TELLOMAK Phase 2 study in advanced Mycosis Fungoides (MF) according to updated guidelines (Olsen 20221) at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2023, being held September 21-23, 2023 in Leiden, the Netherlands. The data confirms clinical activity and favorable safety profile of lacutamab, an anti-KIR3DL2 antibody....
Sep 22, 2023 00:00 ET
Energy Recovery and Epta Win Refrigeration Innovation of the Year at RAC Cooling Industry Awards 2023
Energy Recovery (NASDAQ: ERII) and Epta Group (Epta) were together awarded Refrigeration Innovation of the Year for the XTE (Extra Transcritical Efficiency), Epta’s next-generation commercial CO2 refrigeration system. The award for Refrigeration Innovation of the Year recognizes systems, products, or processes that utilize new technology to provide definitive innovations to refrigeration. The innovative and patent pending XTE solution utilizes the energy savings and efficiency benefits of the PX G1300TM and packages them into a complete next-generation refrigeration syste...